Article
Pfizer ulcerative colitis drug leads to remission in a third of patients -study
Rating:
0.0
Views:
37
Likes:
1
Library:
1
Nearly one third of patients with ulcerative colitis who received an experimental Pfizer Inc drug in a clinical trial were in remission after a year of treatment, the drugmaker said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value